After some early setbacks, AbbVie has scored a second straight victory in its AndroGel legal saga. On Friday, a federal jury sided with the drugmaker over plaintiff Robert Nolte and his legal team, ...

We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up for any (or all) of our 25+ Newsletters. Some states have laws and ethical rules regarding solicitation and ...

AbbVie has suffered its second big AndroGel loss in court. On Thursday, a federal jury ordered the drugmaker to pay more than $140 million to a plaintiff who had a heart attack on the testosterone med ...

ATLANTA (CN) - A federal judge dismissed the remaining claims in a nearly 10-year-old dispute over competition on AndroGel, a drug that boosts testosterone production. In the 1990s, Unimed ...

Are you a male experiencing symptoms of low testosterone such as weight gain and a high-pitched voice? If so, you may want to look into a product by the name of AndroGel. This testosterone gel has ...

(Reuters) - A U.S. judge on Friday overturned a $150 million verdict against AbbVie Inc that was the first to result from lawsuits claiming that the company fraudulently misrepresented the risks of ...

The FDA has approved AndroGel (testosterone gel; Abbott) 1.62% for replacement therapy in adult males for conditions associated with a deficiency or absence of endogenous testosterone, including ...

In a split decision, a federal jury in Chicago ordered AbbVie to pay $150 million in punitive damages for fraudulently misrepresenting the risks of its AndroGel testosterone replacement drug. But at ...

A Collierville man has been awarded more than $140 million in a lawsuit against the makers of a testosterone drug that he says caused him to have a heart attack. A federal court jury in Chicago handed ...

AbbVie must pay $150 million to an Oregon man who accused the pharmaceutical company of misrepresenting the safety risks of its AndroGel drug to treat low testosterone, a federal jury decided Monday ...

AbbVie notched a win late last month in its ongoing battle against thousands of lawsuits that claim AndroGel, a once-blockbuster drug marketed to treat low testosterone in men, causes heart attacks, ...